On June 23rd, we organized the first LUMC Global Community Meeting on establishing successful Sino-Dutch collaborations in (bio)medical research and education.
With broad presence of LUMC professors, researchers, educational staff and researchers from the science faculty of Leiden University, and diplomatic staff of the Dutch Embassy and Consulates in China, we discussed current developments in research & education, R&D, funding opportunities and research ethics in China.
Nico Sciettekatte shared information about the Sino-Dutch (Suzhou) Science and Technology Innovation Park, a park that offers ample opportunity for international collaboration in China. Read more here: https://www.eusinobc.com/sino-dutch-suzhou-science-and-technology-innovation-park/
Annemarie Montulet revealed what it means that China is one of our university’s strategic focus countries, what support is offered and how to approach the topic of knowledge safety in relation to international collaborations. Did you know about this checklist for collaboration with Chinese knowledge institutes?
Furthermore, Yun Tian, Baoxu Pang and Peter ten Dijke proved to be great sources of knowledge and support for anyone taking their first steps in either finding a Chinese PhD or establishing broader institutional collaborations.
Want to learn more about some of the interesting subjects discussed in the meeting? Contact us via firstname.lastname@example.org.
The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.
For many students from the LUMC’s academic programmes, studying abroad is an indispensable experience. Doing part of your studies abroad is a special experience, not only because of the sense of adventure of being abroad, also to develop a broader perspective on Life Sciences & Health, a highly international field. So, you can imagine the LUMC’s International Office’s struggle to have to tell students ‘no’ for a study experience abroad in the midst of the corona pandemic. In addition, the many lockdowns worldwide increased the workload dramatically for the International Office. Evelien Hack, Head of the International Office and Sandra van Deursen, senior administrative assistant, share how corona has impacted studying abroad.
The Leiden University Medical Center (LUMC) and Ixaka Ltd. have announced a research collaboration on 30 March 2021, to better understand REX-001, Ixaka’s lead cell therapy product. The project will be led by Professor Paul Quax, Head of Experimental Vascular Surgery at the LUMC, to support accelerated development of REX-001 in Phase III clinical trials for the treatment of chronic limb-threatening ischemia (CLTI).